Adverse Event Comparison Between Glucagon-Like Peptide-1 Receptor Agonists and Other Antiobesity Medications Following Bariatric Surgery

Version
Adverse Event Comparison Between Glucagon-Like Peptide-1 Receptor Agonists and Other Antiobesity Medications Following Bariatric Surgery

CTSA https://pubmed.ncbi.nlm.nih.gov/38934217/ 2024-06-27T00:00:00Z Diabetes, Obesity and Metabolism